Lannett Company, Inc. (NYSE: LCI) today announced that it has received
interrogatories and subpoena from the State of Connecticut Office of the
Attorney General concerning its investigation into pricing of digoxin.
According to the subpoena, the Connecticut Attorney General is
investigating whether anyone engaged in any activities that resulted in
(a) fixing, maintaining or controlling prices of digoxin or (b)
allocating and dividing customers r territories relating to the sale of
digoxin in violation of Connecticut antitrust law. The Company maintains
that it acted in compliance with all applicable laws and regulations and
intends to cooperate with the Connecticut Attorney General's
About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages,
markets and distributes generic pharmaceutical products for a wide range
of medical indications. For more information, visit the company's
website at www.lannett.com.
[ Back To NFVZone's Homepage ]